Zusammenfassung
Hypertonie gehört zu den häufigsten Ursachen der Gesamtmortalität und ist zu einem hohen Anteil für Todesfälle durch Schlaganfälle, aber auch durch koronare Herzkrankheit verantwortlich. Die krankhafte Erhöhung des Blutdrucks auf Werte, die zu einer Schädigung des Herz-Kreislauf-Systems führen, bezeichnet man als (arterielle) Hypertonie. Blutdruckwerte ab 140/90 mmHg (systolisch/diastolisch) wurden als hypertensiv definiert. Neben genetischer Prädisposition, Alter und Geschlecht spielen das Körpergewicht und Lebensstilfaktoren wie Bewegung und Ernährung eine wichtige Rolle in der Entstehung der Hypertonie. Lebensstiloptimierung zählt zu den wichtigen Maßnahmen sowohl in der Prävention als auch in der Therapie der Hypertonie. In diesem Artikel werden die Ernährungsfaktoren diskutiert, die mit Hypertonie assoziiert sind. Hinsichtlich der Ernährung haben insbesondere eine Reduktion der Kochsalzzufuhr, eine kaliumreiche Kost, Gewichtsmanagement, die DASH (Dietary Approaches to Stop Hypertension)-Diät, ein Ernährungsmuster, das auf einer obst-, gemüse- und getreidereichen Ernährung mit Milch und Milchprodukten mit niedrigem Fettgehalt basiert, sowie ein, wenn überhaupt, nur moderater Alkoholkonsum einen günstigen Einfluss auf den Blutdruck. Basierend auf der wissenschaftlichen Literatur werden in diesem Artikel Ernährungsempfehlungen bei Hypertonie erstellt.
Abstract
Arterial hypertension is one of the leading causes of overall mortality and is responsible for a high proportion of deaths due to stroke as well as coronary heart disease. It is defined as a pathological elevation of blood pressure which leads to damage of the cardiovascular system. Cut-off values for hypertension are defined as blood pressure levels higher than 140/90 mmHg (systolic/diastolic). In the pathogenesis of hypertension genetic factors, age and sex play a role, as well as body weight and lifestyle factors, such as nutrition and physical exercise. Lifestyle optimization reduces the risk of developing hypertension and contributes to the treatment in patients with established hypertension. Nutritional factors associated with hypertension are discussed in this article and recommendations regarding diet are made based on the literature. The nutritional factors with the highest impact on blood pressure are reduction of salt intake, a diet rich in potassium, weight management, the DASH (dietary approach to stop hypertension) diet and moderation of alcohol consumption. Salt restriction is essential in the prevention and treatment of hypertension. Based on the literature, in this article recommendations for nutrition and hypertension are given.
Literatur
Jipp P, Zoller WP (2003) Differenzialdiagnose internistischer Erkrankungen. Urban & Fischer/Elsevier, München, Jena
Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572
Slany J, Magometschnigg D, Mayer G et al (2007) Klassifikation, Diagnostik und Therapie der Hypertonie 2007 – Empfehlungen der Österreichischen Gesellschaft für Hypertensiologie. J Hypertens 11:7–11
Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187
Parati G, Stergiou GS, Asmar R et al; ESH Working Group on Blood Pressure Monitoring (2010) European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 24:779–785
Deutsche Hochdruckliga e.V. DHL® – Deutsche Hypertonie Gesellschaft (2008) Leitlinien zur Behandlung der arteriellen Hypertonie
Rodgers A, Lawes C, Macmahon S (2000) Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens Suppl 18:S3–S6
Dorner T, Rieder A (2004) Epidemiologische Daten zur Hypertonie. J Hypertens 8(Sonderheft 2):4–9
o. A. (1999) 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 17:151–183
Braunwald E, Fauci AS, Kasper DL et al (Hrsg) (2001) Harrison’s Principles of Internal Medicine, 15th edn. McGraw-Hill, New York, S 246
Erbel R, Lehmann N, Mohlenkamp S et al (2012) Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the heinz nixdorf recall study. Hypertension 59:44–53
Braunwald E, Fauci AS, Kasper DL et al (Hrsg) (2001) Harrison’s Principles of Internal Medicine, 15th ed. McGraw-Hill, New York, S 35
o. A. (2003) Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 916:i-viii, 1–149, backcover
Busch J, Feunekes G, Hauer B, Den Hoed W (2010) Salt reduction and the consumer perspective. New Food Mag 2:36–39
Adrogue HJ, Madias NE (2007) Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 356:1966–1978
Elliott P, Stamler J, Nichols R et al (1996) Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 312:1249–1253
Joossens JV, Geboers J (1983) Salt and hypertension. Prev Med 12:53–59
Stamler J (1997) The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 65:626S–642S
Kurtz TW, Al-Bander HA, Morris RC Jr. (1987) „Salt-sensitive“ essential hypertension in men. Is the sodium ion alone important? N Engl J Med 317:1043–1048
Kaplan NM (2010) Salt intake, salt restriction, and essential hypertension. UpToDate. Last literature review version 18.1 (Januar 2010)
Bibbins-Domingo K, Chertow GM, Coxson PG et al (2010) Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 362:590–599
Cook NR, Cutler JA, Obarzanek E et al (2007) Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334:885–888
Jula AM, Karanko HM (1994) Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation 89:1023–1031
He FJ, Macgregor GA (2009) A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 23:363–384
Todd AS, Macginley RJ, Schollum JB et al (2010) Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr 91:557–564
Chen J, Gu D, Huang J et al (2009) Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet 373:829–835
Obarzanek E, Proschan MA, Vollmer WM et al (2003) Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension 42:459–467
Luft FC, Rankin LI, Bloch R et al (1979) Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 60:697–706
Barba G, Galletti F, Cappuccio FP et al (2007) Incidence of hypertension in individuals with different blood pressure salt-sensitivity: results of a 15-year follow-up study. J Hypertens 25:1465–1471
He FJ, Macgregor GA (2003) How far should salt intake be reduced? Hypertension 42:1093–1099
Law MR, Frost CD, Wald NJ (1991) By how much does dietary salt reduction lower blood pressure? I – Analysis of observational data among populations. BMJ 302:811–815
Pimenta E, Gaddam KK, Oparil S et al (2009) Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 54:475–481
Stolarz-Skrzypek K, Kuznetsova T, Thijs L et al (2011) Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305:1777–1785
o. A. (2011) Salt and cardiovascular disease mortality. Lancet 377:1626
Smith-Spangler CM, Juusola JL, Enns EA et al (2010) Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med 152:481–487, W170–W483
Klaus D (2009) Optimale Kochsalzaufnahme? – Gefahren einer generellen Kochsalzbeschränkung. In: Großklaus R, Lampen A, Wittkowski R (Hrsg) Für und Wider einer Salzreduktion in der Gesamtbevölkerung. Tagungsband zum Expertengespräch im Bundesinstitut für Risikobewertung am 15. Oktober 2009, Berlin
Tayie FA, Jourdan K (2010) Hypertension, dietary salt restriction, and iodine deficiency among adults. Am J Hypertens 23:1095–1102
Chobanian AV, Bakris GL, Black HR et al (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252
Langford HG, Schlundt D, Levine K (1984) Sodium restriction in hypertension. Compr Ther 10:6–11
Ram CV, Garrett BN, Kaplan NM (1981) Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med 141:1015–1019
Druml W (2010) Salt kills! Je mehr Salz, desto weniger Lebensjahre. Nutr News 2:2–4
High Level Group on Diet, Physical Activity and Health (2009) National Salt Initiatives implementing the EU framework for salt reduction initiatives. http://ec.europa.eu/health/ph_determinants/life_style/nutrition/documents/national_salt_en.pdf
Karanja N, Lancaster KJ, Vollmer WM et al (2007) Acceptability of sodium-reduced research diets, including the dietary approaches to stop hypertension diet, among adults with prehypertension and stage 1 hypertension. J Am Diet Assoc 107:1530–1538
Paturi M, Tapanainen H, Pietinen P (Hrsg) (2008) The National FINDIET 2007 Survey. Publications of the National Public Health Institute, B23/2008
Agency FS (2008) An assessment of dietary sodium levels among adults (aged 19–64) in the UK general population in 2008, based on analysis of dietary sodium in 24 hour urine samples. June 2008. http://www.food.gov.uk/multimedia/pdfs/sodiumreport08.pdf
Green DM, Ropper AH, Kronmal RA et al (2002) Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology 59:314–320
Siani A, Strazzullo P, Giacco A et al (1991) Increasing the dietary potassium intake reduces the need for antihypertensive medication. Ann Intern Med 115:753–759
Geleijnse JM, Kok FJ, Grobbee DE (2003) Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 17:471–480
Whelton PK, He J, Cutler JA et al (1997) Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277:1624–1632
Dickinson HO, Nicolson DJ, Campbell F et al (2006) Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 3:CD004641
Morris RC Jr, Schmidlin O, Tanaka M et al (1999) Differing effects of supplemental KCl and KHCO3: pathophysiological and clinical implications. Semin Nephrol 19:487–493
Bianchetti MG, Weidmann P, Beretta-Piccoli C, Ferrier C (1987) Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension. Kidney Int 31:956–963
Barri YM, Wingo CS (1997) The effects of potassium depletion and supplementation on blood pressure: a clinical review. Am J Med Sci 314:37–40
Gallen IW, Rosa RM, Esparaz DY et al (1998) On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. Am J Kidney Dis 31:19–27
Whelton PK, He J (1999) Potassium in preventing and treating high blood pressure. Semin Nephrol 19:494–499
Wilson PW, D’agostino RB, Sullivan L et al (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:1867–1872
Moore LL, Visioni AJ, Qureshi MM et al (2005) Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. Arch Intern Med 165:1298–1303
Huang Z, Willett WC, Manson JE et al (1998) Body weight, weight change, and risk for hypertension in women. Ann Intern Med 128:81–88
Nyamdorj R, Qiao Q, Soderberg S et al (2008) Comparison of body mass index with waist circumference, waist-to-hip ratio, and waist-to-stature ratio as a predictor of hypertension incidence in Mauritius. J Hypertens 26:866–870
Schmieder RE, Messerli FH (1993) Does obesity influence early target organ damage in hypertensive patients? Circulation 87:1482–1488
Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK (2005) Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 46:1316–1320
Rahmouni K, Correia ML, Haynes WG, Mark AL (2005) Obesity-associated hypertension: new insights into mechanisms. Hypertension 45:9–14
Steinberg HO, Chaker H, Leaming R et al (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601–2610
Gorzelniak K, Engeli S, Janke J et al (2002) Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 20:965–973
Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A (2008) Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 26:831–843
Goodfriend TL, Calhoun DA (2004) Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43:518–524
Phillips BG, Narkiewicz K, Pesek CA et al (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66
Horvath K, Jeitler K, Siering U et al (2008) Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis. Arch Intern Med 168:571–580
Aucott L, Poobalan A, Smith WC et al (2005) Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension 45:1035–1041
Appel LJ, Moore TJ, Obarzanek E et al (1997) A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336:1117–1124
Sacks FM, Svetkey LP, Vollmer WM et al (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344:3–10
Appel LJ, Champagne CM, Harsha DW et al (2003) Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 289:2083–2093
Elmer PJ, Obarzanek E, Vollmer WM et al (2006) Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 144:485–495
Lin PH, Appel LJ, Funk K et al (2007) The PREMIER intervention helps participants follow the dietary approaches to stop hypertension dietary pattern and the current dietary reference intakes recommendations. J Am Diet Assoc 107:1541–1551
Appel LJ, Sacks FM, Carey VJ et al (2005) Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294:2455–2464
Blumenthal JA, Babyak MA, Hinderliter A et al (2010) Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 170:126–135
Fung TT, Chiuve SE, Mccullough ML et al (2008) Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med 168:713–720
Appel LJ, Giles TD, Black HR et al (2009) ASH Position Paper: Dietary approaches to lower blood pressure. J Clin Hypertens (Greenwich) 11:358–368
Dickinson HO, Mason JM, Nicolson DJ et al (2006) Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 24:215–233
Deutsche Gesellschaft Für Ernährung e. V.(2009) Beratungs-Standards 2009. Kap. 5.4.1
Kaplan NM, Rose BD (2009) Diet in the treatment and prevention of hypertension. UpToDate. Last literature review version 17.3 (2009)
Khan NA, Hemmelgarn B, Herman RJ et al (2009) The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy. Can J Cardiol 25:287–298
Reid IR, Ames R, Mason B et al (2010) Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr 91:131–139
Judd SE, Tangpricha V (2009) Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 338:40–44
Pilz S, Tomaschitz A, Ritz E, Pieber TR (2009) Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 6:621–630
Pittas AG, Chung M, Trikalinos T et al (2010) Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 152:307–314
Krause T, Lovibond K, Caulfield M et al; Guideline Development Group (2011) Management of hypertension: summary of NICE guidance. BMJ 343:d4891
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Additional information
In Kooperation mit Prof. Watschinger und Prof. Slany von der Österreichischen Gesellschaft für Hypertensiologie.
Hinweis und Danksagung
Das Manuskript wurde von Univ.-Prof. Dr. Ibrahim Elmadfa, Präsident der Österreichischen Gesellschaft für Ernährung (ÖGE) und Präsident der IUNS (International Union of Nutritional Sciences), in Auftrag gegeben. Die Autoren bedanken sich bei ihm und bei Fr. Mag. Alexandra Hofer, Geschäftsführerin der ÖGE, für ihre Unterstützung.
Rights and permissions
About this article
Cite this article
Dorner, T., Genser, D., Krejs, G. et al. Hypertonie und Ernährung. Herz 38, 153–162 (2013). https://doi.org/10.1007/s00059-012-3613-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-012-3613-1